SubjectWell Acquires PatientCentra

Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications

AUSTIN, Texas–(BUSINESS WIRE)–SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers full-service, global patient recruitment capabilities plus an in-house agency for the development of tailored, patient-centric recruitment journeys. Through this acquisition, SubjectWell now serves the patient recruitment needs of any international clinical study, while expanding its ability to recruit for rare disease and oncology indications.


“SubjectWell’s global customer base has been asking for our recruitment support on large, multi-country trials – and we listened,” said Fred Martin, CEO, SubjectWell. “PatientCentra has 15 years of experience delivering digitally enabled patient recruitment programs on five different continents. When added to SubjectWell’s unrivaled access to motivated patients with known conditions in North America, together we accelerate our ability to support life-improving research on a global scale.”

“The PatientCentra team and I are proud to be joining SubjectWell,” said Dan Stempel, founder and CEO, PatientCentra. “We see a huge opportunity to offer our customized clinical recruitment solutions, including multi-channel outreach, patient websites and concierge support to SubjectWell’s marquee customer base. Our combined customers can now rely on one company for end-to-end, global patient recruitment support for vaccine, chronic conditions, rare disease, and oncology studies.”

About SubjectWell

SubjectWell is the patient access marketplace, connecting patients with chronic health conditions to trials and treatments. Since 2012, SubjectWell has been raising awareness of the benefits of clinical research, registering tens of millions of healthcare-motivated patients with known conditions. At SubjectWell, we already have the patients you need. Visit www.SubjectWell.com to find out more.

About MD Connect, Inc.

For more than 15 years, MD Connect, Inc. has helped hundreds of leading healthcare organizations acquire patients using customized multi-channel digital outreach and patient lead tracking technologies. Backed by data and the experience of having driven millions of patient leads in over 30 specialties, MD Connect, Inc. leverages their knowledge base to map custom digital patient journeys that go well beyond an initial patient inquiry. PatientCentra, the largest and fastest growing component of MD Connect, Inc., provides global patient recruitment and compliance services, combining innovative outreach strategies with state-of-the-art technologies and a suite of site support services designed to ease the burden on patients, sites, and sponsors. Find out more at PatientCentra.com.

Contacts

Jillian Hammell

Crowley Webb for SubjectWell

[email protected], 716.844.7237

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.